Arvinas logo
Close this search box.

PROTAC® targeted protein degraders: the past is prologue. Nature Reviews Drug Discovery

Miklós Békés, et al.

January 18, 2022
Nature Reviews Drug Discovery


You are now leaving Arvinas does not endorse or recommend the content in any third-party sites. Arvinas is not responsible and disclaims liability for the content, or for any viruses or similar harmful programs, that may be present on third-party pages or sites. Visits to a third-party website are at your own risk and subject to the terms and conditions and privacy policy of such site.

Skip to content